DMK PHARMACEUTICALS Corp Quarterly Common Stock, Shares, Outstanding from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
DMK PHARMACEUTICALS Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2011 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 10.1M shares, a 93.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 10.1M -140M -93.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 2.79M -147M -98.1% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 166M +16.8M +11.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 2.14M -147M -98.6% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 150M +1.1M +0.74% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 150M +1.1M +0.74% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 150M +847K +0.57% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 150M +55.8M +59.4% Dec 31, 2021 10-K 2023-03-16
Q3 2021 149M +55.2M +59% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 149M +75M +101% Jun 30, 2021 10-Q 2021-11-22
Q1 2021 149M +75.2M +102% Mar 31, 2021 10-Q 2021-11-22
Q4 2020 93.8M +32M +51.8% Dec 31, 2020 10-K 2022-03-31
Q3 2020 93.7M +32M +52% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 73.9M +26.3M +55.2% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 73.7M +26.3M +55.4% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 61.8M +14.5M +30.7% Dec 31, 2019 10-K 2021-04-15
Q3 2019 61.6M +14.3M +30.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 47.6M +14.2M +42.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 47.4M +14.1M +42.1% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 47.3M +13.9M +41.6% Dec 31, 2018 10-K 2020-03-30
Q3 2018 47.3M +13.9M +41.6% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 33.4M +5.72M +20.7% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 33.4M +10.8M +47.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 33.4M +11.4M +51.8% Dec 31, 2017 10-K 2019-03-15
Q3 2017 33.4M +12.5M +59.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 27.7M +10.4M +59.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 22.6M +9.18M +68.2% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 22M +8.56M +63.7% Dec 31, 2016 10-K 2018-03-16
Q3 2016 20.9M +7.46M +55.5% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 17.3M +3.88M +28.9% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 13.5M +35.7K +0.27% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 13.4M +2.78M +26.1% Dec 31, 2015 10-K 2017-03-30
Q3 2015 13.4M +2.93M +27.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 13.4M +2.93M +27.9% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 13.4M +2.92M +27.8% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 10.7M +740K +7.47% Dec 31, 2014 10-K 2016-03-23
Q3 2014 10.5M -94.4M -90% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 10.5M -93.9M -89.9% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 10.5M +4.36M +70.9% Mar 31, 2014 10-KT 2015-03-26
Q4 2013 9.91M -93.6M -90.4% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 105M +6.53M +6.64% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 104M +6.28M +6.4% Jun 30, 2013 10-Q 2013-08-19
Q1 2013 6.14M -89.8M -93.6% Mar 31, 2013 10-K 2014-06-23
Q4 2012 104M +10.4M +11.1% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 98.3M +8.01M +8.87% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 98.1M +10.3M +11.7% Jun 30, 2012 10-Q/A 2012-08-17
Q1 2012 95.9M +14.3M +17.6% Mar 31, 2012 10-K 2013-07-03
Q4 2011 93.1M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 90.3M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 87.9M Jun 30, 2011 10-Q 2011-08-15
Q1 2011 81.6M Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.